Back to top

Early AF Treatment on Trial: What Abbott’s PULSE Study Could Mean for Investors

Abbott Laboratories ($ABT) announced an update on their ongoing clinical study. The PULSE Study is a new trial looking at early treatment for atria...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Abbott Laboratories (ABT)